These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Endogenous ligand of alpha(1) sodium pump, marinobufagenin, is a novel mediator of sodium chloride--dependent hypertension. Fedorova OV; Talan MI; Agalakova NI; Lakatta EG; Bagrov AY Circulation; 2002 Mar; 105(9):1122-7. PubMed ID: 11877366 [TBL] [Abstract][Full Text] [Related]
3. Digoxin antibody decreases natriuresis and diuresis in cerebral hemorrhage. Menezes JC; Troster EJ; Dichtchekenian V Intensive Care Med; 2003 Dec; 29(12):2291-2296. PubMed ID: 12955184 [TBL] [Abstract][Full Text] [Related]
4. Increases in CSF [Na+] precede the increases in blood pressure in Dahl S rats and SHR on a high-salt diet. Huang BS; Van Vliet BN; Leenen FH Am J Physiol Heart Circ Physiol; 2004 Sep; 287(3):H1160-6. PubMed ID: 15130889 [TBL] [Abstract][Full Text] [Related]
5. Effects of intracerebroventricular infusion of Fab fragments of digoxin antibody (Digibind) on development of reduced renal mass-saline hypertension in rats. Yamada K; Goto A; Hui C; Nagoshi H; Omata M Hypertens Res; 1995 Jun; 18(2):145-50. PubMed ID: 7584921 [TBL] [Abstract][Full Text] [Related]
6. Brain sodium channels and central sodium-induced increases in brain ouabain-like compound and blood pressure. Wang H; Leenen FH J Hypertens; 2003 Aug; 21(8):1519-24. PubMed ID: 12872046 [TBL] [Abstract][Full Text] [Related]
7. Volume sensitive hypertension and the digoxin-like factor. Reversal by a Fab directed against digoxin in DOCA-salt hypertensive rats. Krep H; Price DA; Soszynski P; Tao QF; Graves SW; Hollenberg NK Am J Hypertens; 1995 Sep; 8(9):921-7. PubMed ID: 8541008 [TBL] [Abstract][Full Text] [Related]
8. Different effects of in vivo ouabain and digoxin on renal artery function and blood pressure in the rat. Kimura K; Manunta P; Hamilton BP; Hamlyn JM Hypertens Res; 2000 Sep; 23 Suppl():S67-76. PubMed ID: 11016823 [TBL] [Abstract][Full Text] [Related]
9. Effect of endogenous digoxin-like factor and digoxin antibody on myocardial Na+, K(+)-pump activity and ventricular arrhythmias in acute myocardial ischaemia in rats. Bagrov AY; Fedorova OV; Roukoyatkina NI; Zhabko EP Cardiovasc Res; 1993 Jun; 27(6):1045-50. PubMed ID: 8221762 [TBL] [Abstract][Full Text] [Related]
10. Brain sodium channels and ouabainlike compounds mediate central aldosterone-induced hypertension. Wang H; Huang BS; Leenen FH Am J Physiol Heart Circ Physiol; 2003 Dec; 285(6):H2516-23. PubMed ID: 12933342 [TBL] [Abstract][Full Text] [Related]
11. Role of ouabain-like compound in the rostral ventrolateral medulla in rats. Teruya H; Yamazato M; Muratani H; Sakima A; Takishita S; Terano Y; Fukiyama K J Clin Invest; 1997 Jun; 99(11):2791-8. PubMed ID: 9169510 [TBL] [Abstract][Full Text] [Related]
12. Effects of digoxin-specific antibody Fab fragment (Digibind) on blood pressure and renal water-sodium metabolism in 5/6 reduced renal mass hypertensive rats. Kaide J; Ura N; Torii T; Nakagawa M; Takada T; Shimamoto K Am J Hypertens; 1999 Jun; 12(6):611-9. PubMed ID: 10371371 [TBL] [Abstract][Full Text] [Related]
14. Hypotensive action of canrenone in a model of hypertension where ouabain-like factors are present. De Mendonca M; Grichois ML; Pernollet MG; Thorman B; Meyer P; Devynck MA; Garay R J Hypertens Suppl; 1985 Dec; 3(3):S73-5. PubMed ID: 2856827 [TBL] [Abstract][Full Text] [Related]
15. Effects of the Fab fragment of digoxin antibody on the natriuresis and increase in blood pressure induced by intracerebroventricular infusion of hypertonic saline solution in rats. Yamada K; Goto A; Hui C; Yagi N; Sugimoto T Clin Sci (Lond); 1992 Jun; 82(6):625-30. PubMed ID: 1320541 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the neutralizing activity of digoxin-specific Fab toward ouabain-like steroids. Pullen MA; Brooks DP; Edwards RM J Pharmacol Exp Ther; 2004 Jul; 310(1):319-25. PubMed ID: 14982968 [TBL] [Abstract][Full Text] [Related]
17. Vasoactive role of endogenous digoxin-like factor in rats with experimental hypertension. Pohlová I; Kunes J; Stolba P; JelĂnek J; Zicha J Cor Vasa; 1986; 28(4):298-305. PubMed ID: 3021389 [TBL] [Abstract][Full Text] [Related]
18. Digoxin-binding antibodies reverse the effect of endogenous digitalis-like compounds on Na,K-ATPase in erythrocytes. Balzan S; Montali U; Biver P; Ghione S J Hypertens Suppl; 1991 Dec; 9(6):S304-5. PubMed ID: 1668002 [No Abstract] [Full Text] [Related]